Global Non-24-hour Sleep-wake Disorder Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Non-24-hour Sleep-wake Disorder Treatment market size was valued at USD 493.9 million in 2022 and is forecast to a readjusted size of USD 734.7 million by 2029 with a CAGR of 5.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual's biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
This report is a detailed and comprehensive analysis for global Non-24-hour Sleep-wake Disorder Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-24-hour Sleep-wake Disorder Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-24-hour Sleep-wake Disorder Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-24-hour Sleep-wake Disorder Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-24-hour Sleep-wake Disorder Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-24-hour Sleep-wake Disorder Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-24-hour Sleep-wake Disorder Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite) and Boiron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-24-hour Sleep-wake Disorder Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Non-24-hour Sleep-wake Disorder Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-24-hour Sleep-wake Disorder Treatment, with revenue, gross margin and global market share of Non-24-hour Sleep-wake Disorder Treatment from 2018 to 2023.
Chapter 3, the Non-24-hour Sleep-wake Disorder Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-24-hour Sleep-wake Disorder Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-24-hour Sleep-wake Disorder Treatment.
Chapter 13, to describe Non-24-hour Sleep-wake Disorder Treatment research findings and conclusion.
Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual's biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
This report is a detailed and comprehensive analysis for global Non-24-hour Sleep-wake Disorder Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-24-hour Sleep-wake Disorder Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-24-hour Sleep-wake Disorder Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-24-hour Sleep-wake Disorder Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-24-hour Sleep-wake Disorder Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-24-hour Sleep-wake Disorder Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-24-hour Sleep-wake Disorder Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite) and Boiron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-24-hour Sleep-wake Disorder Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Prescription Drugs
- OTC
- Hospital Pharmacies
- Retail Pharmacies
- Other
- Teva
- Mylan
- Nature’s Bounty
- Otsuka Pharma (Pharmavite)
- Boiron
- Miers Laboratories
- Genexa
- Homeocan
- Clinigen Group
- Vanda Pharma
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Non-24-hour Sleep-wake Disorder Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-24-hour Sleep-wake Disorder Treatment, with revenue, gross margin and global market share of Non-24-hour Sleep-wake Disorder Treatment from 2018 to 2023.
Chapter 3, the Non-24-hour Sleep-wake Disorder Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-24-hour Sleep-wake Disorder Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-24-hour Sleep-wake Disorder Treatment.
Chapter 13, to describe Non-24-hour Sleep-wake Disorder Treatment research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-24-hour Sleep-wake Disorder Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-24-hour Sleep-wake Disorder Treatment by Type
1.3.1 Overview: Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type in 2022
1.3.3 Prescription Drugs
1.3.4 OTC
1.4 Global Non-24-hour Sleep-wake Disorder Treatment Market by Application
1.4.1 Overview: Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Other
1.5 Global Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecast
1.6 Global Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast by Region
1.6.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region, (2018-2029)
1.6.3 North America Non-24-hour Sleep-wake Disorder Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Non-24-hour Sleep-wake Disorder Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.1.4 Teva Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva Recent Developments and Future Plans
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.2.4 Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mylan Recent Developments and Future Plans
2.3 Nature’s Bounty
2.3.1 Nature’s Bounty Details
2.3.2 Nature’s Bounty Major Business
2.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.3.4 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Nature’s Bounty Recent Developments and Future Plans
2.4 Otsuka Pharma (Pharmavite)
2.4.1 Otsuka Pharma (Pharmavite) Details
2.4.2 Otsuka Pharma (Pharmavite) Major Business
2.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.4.4 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Otsuka Pharma (Pharmavite) Recent Developments and Future Plans
2.5 Boiron
2.5.1 Boiron Details
2.5.2 Boiron Major Business
2.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.5.4 Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boiron Recent Developments and Future Plans
2.6 Miers Laboratories
2.6.1 Miers Laboratories Details
2.6.2 Miers Laboratories Major Business
2.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.6.4 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Miers Laboratories Recent Developments and Future Plans
2.7 Genexa
2.7.1 Genexa Details
2.7.2 Genexa Major Business
2.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.7.4 Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Genexa Recent Developments and Future Plans
2.8 Homeocan
2.8.1 Homeocan Details
2.8.2 Homeocan Major Business
2.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.8.4 Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Homeocan Recent Developments and Future Plans
2.9 Clinigen Group
2.9.1 Clinigen Group Details
2.9.2 Clinigen Group Major Business
2.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.9.4 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Clinigen Group Recent Developments and Future Plans
2.10 Vanda Pharma
2.10.1 Vanda Pharma Details
2.10.2 Vanda Pharma Major Business
2.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.10.4 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Vanda Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-24-hour Sleep-wake Disorder Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-24-hour Sleep-wake Disorder Treatment by Company Revenue
3.2.2 Top 3 Non-24-hour Sleep-wake Disorder Treatment Players Market Share in 2022
3.2.3 Top 6 Non-24-hour Sleep-wake Disorder Treatment Players Market Share in 2022
3.3 Non-24-hour Sleep-wake Disorder Treatment Market: Overall Company Footprint Analysis
3.3.1 Non-24-hour Sleep-wake Disorder Treatment Market: Region Footprint
3.3.2 Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Type Footprint
3.3.3 Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2029)
6.2 North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2029)
6.3 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
6.3.1 North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2029)
7.2 Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2029)
7.3 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
7.3.1 Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
7.3.3 France Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.3.1 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2018-2029)
8.3.2 China Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8.3.5 India Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2029)
9.2 South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2029)
9.3 South America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
9.3.1 South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
10.3.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-24-hour Sleep-wake Disorder Treatment Market Drivers
11.2 Non-24-hour Sleep-wake Disorder Treatment Market Restraints
11.3 Non-24-hour Sleep-wake Disorder Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-24-hour Sleep-wake Disorder Treatment Industry Chain
12.2 Non-24-hour Sleep-wake Disorder Treatment Upstream Analysis
12.3 Non-24-hour Sleep-wake Disorder Treatment Midstream Analysis
12.4 Non-24-hour Sleep-wake Disorder Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Non-24-hour Sleep-wake Disorder Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-24-hour Sleep-wake Disorder Treatment by Type
1.3.1 Overview: Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type in 2022
1.3.3 Prescription Drugs
1.3.4 OTC
1.4 Global Non-24-hour Sleep-wake Disorder Treatment Market by Application
1.4.1 Overview: Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Other
1.5 Global Non-24-hour Sleep-wake Disorder Treatment Market Size & Forecast
1.6 Global Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast by Region
1.6.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region, (2018-2029)
1.6.3 North America Non-24-hour Sleep-wake Disorder Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Non-24-hour Sleep-wake Disorder Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.1.4 Teva Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva Recent Developments and Future Plans
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.2.4 Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mylan Recent Developments and Future Plans
2.3 Nature’s Bounty
2.3.1 Nature’s Bounty Details
2.3.2 Nature’s Bounty Major Business
2.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.3.4 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Nature’s Bounty Recent Developments and Future Plans
2.4 Otsuka Pharma (Pharmavite)
2.4.1 Otsuka Pharma (Pharmavite) Details
2.4.2 Otsuka Pharma (Pharmavite) Major Business
2.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.4.4 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Otsuka Pharma (Pharmavite) Recent Developments and Future Plans
2.5 Boiron
2.5.1 Boiron Details
2.5.2 Boiron Major Business
2.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.5.4 Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boiron Recent Developments and Future Plans
2.6 Miers Laboratories
2.6.1 Miers Laboratories Details
2.6.2 Miers Laboratories Major Business
2.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.6.4 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Miers Laboratories Recent Developments and Future Plans
2.7 Genexa
2.7.1 Genexa Details
2.7.2 Genexa Major Business
2.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.7.4 Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Genexa Recent Developments and Future Plans
2.8 Homeocan
2.8.1 Homeocan Details
2.8.2 Homeocan Major Business
2.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.8.4 Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Homeocan Recent Developments and Future Plans
2.9 Clinigen Group
2.9.1 Clinigen Group Details
2.9.2 Clinigen Group Major Business
2.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.9.4 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Clinigen Group Recent Developments and Future Plans
2.10 Vanda Pharma
2.10.1 Vanda Pharma Details
2.10.2 Vanda Pharma Major Business
2.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
2.10.4 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Vanda Pharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-24-hour Sleep-wake Disorder Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-24-hour Sleep-wake Disorder Treatment by Company Revenue
3.2.2 Top 3 Non-24-hour Sleep-wake Disorder Treatment Players Market Share in 2022
3.2.3 Top 6 Non-24-hour Sleep-wake Disorder Treatment Players Market Share in 2022
3.3 Non-24-hour Sleep-wake Disorder Treatment Market: Overall Company Footprint Analysis
3.3.1 Non-24-hour Sleep-wake Disorder Treatment Market: Region Footprint
3.3.2 Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Type Footprint
3.3.3 Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2029)
6.2 North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2029)
6.3 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
6.3.1 North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2029)
7.2 Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2029)
7.3 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
7.3.1 Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
7.3.3 France Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region
8.3.1 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2018-2029)
8.3.2 China Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8.3.5 India Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2029)
9.2 South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2029)
9.3 South America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
9.3.1 South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country
10.3.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Non-24-hour Sleep-wake Disorder Treatment Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-24-hour Sleep-wake Disorder Treatment Market Drivers
11.2 Non-24-hour Sleep-wake Disorder Treatment Market Restraints
11.3 Non-24-hour Sleep-wake Disorder Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-24-hour Sleep-wake Disorder Treatment Industry Chain
12.2 Non-24-hour Sleep-wake Disorder Treatment Upstream Analysis
12.3 Non-24-hour Sleep-wake Disorder Treatment Midstream Analysis
12.4 Non-24-hour Sleep-wake Disorder Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Teva Company Information, Head Office, and Major Competitors
Table 6. Teva Major Business
Table 7. Teva Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 8. Teva Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Teva Recent Developments and Future Plans
Table 10. Mylan Company Information, Head Office, and Major Competitors
Table 11. Mylan Major Business
Table 12. Mylan Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 13. Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Mylan Recent Developments and Future Plans
Table 15. Nature’s Bounty Company Information, Head Office, and Major Competitors
Table 16. Nature’s Bounty Major Business
Table 17. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 18. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Nature’s Bounty Recent Developments and Future Plans
Table 20. Otsuka Pharma (Pharmavite) Company Information, Head Office, and Major Competitors
Table 21. Otsuka Pharma (Pharmavite) Major Business
Table 22. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 23. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Otsuka Pharma (Pharmavite) Recent Developments and Future Plans
Table 25. Boiron Company Information, Head Office, and Major Competitors
Table 26. Boiron Major Business
Table 27. Boiron Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 28. Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Boiron Recent Developments and Future Plans
Table 30. Miers Laboratories Company Information, Head Office, and Major Competitors
Table 31. Miers Laboratories Major Business
Table 32. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 33. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Miers Laboratories Recent Developments and Future Plans
Table 35. Genexa Company Information, Head Office, and Major Competitors
Table 36. Genexa Major Business
Table 37. Genexa Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 38. Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Genexa Recent Developments and Future Plans
Table 40. Homeocan Company Information, Head Office, and Major Competitors
Table 41. Homeocan Major Business
Table 42. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 43. Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Homeocan Recent Developments and Future Plans
Table 45. Clinigen Group Company Information, Head Office, and Major Competitors
Table 46. Clinigen Group Major Business
Table 47. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 48. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Clinigen Group Recent Developments and Future Plans
Table 50. Vanda Pharma Company Information, Head Office, and Major Competitors
Table 51. Vanda Pharma Major Business
Table 52. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 53. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Vanda Pharma Recent Developments and Future Plans
Table 55. Global Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million) by Players (2018-2023)
Table 56. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Players (2018-2023)
Table 57. Breakdown of Non-24-hour Sleep-wake Disorder Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Non-24-hour Sleep-wake Disorder Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Non-24-hour Sleep-wake Disorder Treatment Players
Table 60. Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Type Footprint
Table 61. Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Application Footprint
Table 62. Non-24-hour Sleep-wake Disorder Treatment New Market Entrants and Barriers to Market Entry
Table 63. Non-24-hour Sleep-wake Disorder Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Share by Type (2018-2023)
Table 66. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Forecast by Type (2024-2029)
Table 67. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023)
Table 68. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Forecast by Application (2024-2029)
Table 69. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Non-24-hour Sleep-wake Disorder Treatment Raw Material
Table 100. Key Suppliers of Non-24-hour Sleep-wake Disorder Treatment Raw Materials
Table 1. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Teva Company Information, Head Office, and Major Competitors
Table 6. Teva Major Business
Table 7. Teva Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 8. Teva Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Teva Recent Developments and Future Plans
Table 10. Mylan Company Information, Head Office, and Major Competitors
Table 11. Mylan Major Business
Table 12. Mylan Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 13. Mylan Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Mylan Recent Developments and Future Plans
Table 15. Nature’s Bounty Company Information, Head Office, and Major Competitors
Table 16. Nature’s Bounty Major Business
Table 17. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 18. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Nature’s Bounty Recent Developments and Future Plans
Table 20. Otsuka Pharma (Pharmavite) Company Information, Head Office, and Major Competitors
Table 21. Otsuka Pharma (Pharmavite) Major Business
Table 22. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 23. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Otsuka Pharma (Pharmavite) Recent Developments and Future Plans
Table 25. Boiron Company Information, Head Office, and Major Competitors
Table 26. Boiron Major Business
Table 27. Boiron Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 28. Boiron Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Boiron Recent Developments and Future Plans
Table 30. Miers Laboratories Company Information, Head Office, and Major Competitors
Table 31. Miers Laboratories Major Business
Table 32. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 33. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Miers Laboratories Recent Developments and Future Plans
Table 35. Genexa Company Information, Head Office, and Major Competitors
Table 36. Genexa Major Business
Table 37. Genexa Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 38. Genexa Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Genexa Recent Developments and Future Plans
Table 40. Homeocan Company Information, Head Office, and Major Competitors
Table 41. Homeocan Major Business
Table 42. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 43. Homeocan Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Homeocan Recent Developments and Future Plans
Table 45. Clinigen Group Company Information, Head Office, and Major Competitors
Table 46. Clinigen Group Major Business
Table 47. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 48. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Clinigen Group Recent Developments and Future Plans
Table 50. Vanda Pharma Company Information, Head Office, and Major Competitors
Table 51. Vanda Pharma Major Business
Table 52. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product and Solutions
Table 53. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Vanda Pharma Recent Developments and Future Plans
Table 55. Global Non-24-hour Sleep-wake Disorder Treatment Revenue (USD Million) by Players (2018-2023)
Table 56. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Players (2018-2023)
Table 57. Breakdown of Non-24-hour Sleep-wake Disorder Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Non-24-hour Sleep-wake Disorder Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Non-24-hour Sleep-wake Disorder Treatment Players
Table 60. Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Type Footprint
Table 61. Non-24-hour Sleep-wake Disorder Treatment Market: Company Product Application Footprint
Table 62. Non-24-hour Sleep-wake Disorder Treatment New Market Entrants and Barriers to Market Entry
Table 63. Non-24-hour Sleep-wake Disorder Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Share by Type (2018-2023)
Table 66. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Forecast by Type (2024-2029)
Table 67. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023)
Table 68. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Forecast by Application (2024-2029)
Table 69. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Non-24-hour Sleep-wake Disorder Treatment Raw Material
Table 100. Key Suppliers of Non-24-hour Sleep-wake Disorder Treatment Raw Materials
LIST OF FIGURES
Figure 1. Non-24-hour Sleep-wake Disorder Treatment Picture
Figure 2. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type in 2022
Figure 4. Prescription Drugs
Figure 5. OTC
Figure 6. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Other Picture
Figure 11. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Non-24-hour Sleep-wake Disorder Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Region in 2022
Figure 16. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Players in 2022
Figure 22. Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Non-24-hour Sleep-wake Disorder Treatment Market Share in 2022
Figure 24. Global Top 6 Players Non-24-hour Sleep-wake Disorder Treatment Market Share in 2022
Figure 25. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Share by Type (2018-2023)
Figure 26. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Type (2024-2029)
Figure 27. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Share by Application (2018-2023)
Figure 28. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Application (2024-2029)
Figure 29. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 39. France Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 46. China Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 49. India Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 63. Non-24-hour Sleep-wake Disorder Treatment Market Drivers
Figure 64. Non-24-hour Sleep-wake Disorder Treatment Market Restraints
Figure 65. Non-24-hour Sleep-wake Disorder Treatment Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Non-24-hour Sleep-wake Disorder Treatment in 2022
Figure 68. Manufacturing Process Analysis of Non-24-hour Sleep-wake Disorder Treatment
Figure 69. Non-24-hour Sleep-wake Disorder Treatment Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Non-24-hour Sleep-wake Disorder Treatment Picture
Figure 2. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type in 2022
Figure 4. Prescription Drugs
Figure 5. OTC
Figure 6. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Other Picture
Figure 11. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Non-24-hour Sleep-wake Disorder Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Region in 2022
Figure 16. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Players in 2022
Figure 22. Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Non-24-hour Sleep-wake Disorder Treatment Market Share in 2022
Figure 24. Global Top 6 Players Non-24-hour Sleep-wake Disorder Treatment Market Share in 2022
Figure 25. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Share by Type (2018-2023)
Figure 26. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Type (2024-2029)
Figure 27. Global Non-24-hour Sleep-wake Disorder Treatment Consumption Value Share by Application (2018-2023)
Figure 28. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Application (2024-2029)
Figure 29. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 39. France Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Region (2018-2029)
Figure 46. China Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 49. India Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Non-24-hour Sleep-wake Disorder Treatment Consumption Value (2018-2029) & (USD Million)
Figure 63. Non-24-hour Sleep-wake Disorder Treatment Market Drivers
Figure 64. Non-24-hour Sleep-wake Disorder Treatment Market Restraints
Figure 65. Non-24-hour Sleep-wake Disorder Treatment Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Non-24-hour Sleep-wake Disorder Treatment in 2022
Figure 68. Manufacturing Process Analysis of Non-24-hour Sleep-wake Disorder Treatment
Figure 69. Non-24-hour Sleep-wake Disorder Treatment Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
